The<unk>  trial randomized 41 021 patients with acute myocardial infarction and ST segment elevation within 6 hours of symptom onset to one of four thrombolytic strategies.
Enrollment was not restricted because of age or presentation in cardiogenic shock. Patients were excluded if they had prior stroke, active or recent bleeding, recent trauma or major surgery, non compressible vascular punctures, or previous treatment with streptokinase or anistreplase.
GUSTO-I
ASHRAE
G-LOC
SMAS
AEMT-CC
TNM
Lncap
XMC